Zai Lab Ltd at Citi BioPharma Conference (Virtual) Transcript
Okay, great. So welcome, everyone, to the third day of the Citi Biopharma Conference. I'm Yigal Nochomovitz, one of the Biotech analysts. (Operator Instructions). So it's my great pleasure to have with me this morning, Samantha Du, the CEO of Zai Lab, one of the companies I cover.
Questions & Answers
And maybe as a starting point, Samantha, just to get everyone oriented, if you could give us a 3- or 4-minute overview of Zai Lab, just highlighting some of the key assets in the pipeline and where you stand with your commercial efforts for ZEJULA and Optune.
Yes. Good morning, Yigal, and thank you for your opening remarks. Since our inception in 2014, we have executed our two-pronged strategy through both in-licensing of potentially best-in-class and first-in-class assets and investing in internal R&D efforts. Today,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
